Samir Gharib
Finanzdirektor/CFO bei SPRUCE BIOSCIENCES, INC.
Vermögen: 150 257 $ am 31.05.2024
Aktive Positionen von Samir Gharib
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Finanzdirektor/CFO | 01.05.2020 | - |
| Präsident | 01.01.2022 | - | |
| Cancer CAREpoint | Direktor/Vorstandsmitglied | 01.11.2017 | - |
Karriereverlauf von Samir Gharib
Ehemalige bekannte Positionen von Samir Gharib
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Stemedica Cell Technologies, Inc.
 Stemedica Cell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Stemedica Cell Technologies, Inc. operates as a biotechnology company that manufactures adult allergenic stem cells. Its adult stem cells which are used by research institutions and hospitals for pre-clinical and clinical studies. It has offices in Mexico, Italy, Switzerland, and France. The company was founded by Roger J. Howe and Maynard A. Howe in 2005 and is headquartered in San Diego, CA. | Finanzdirektor/CFO | 01.10.2018 | 01.09.2019 |
| Benchmark Financial Partners LLC | Corporate Officer/Principal | 01.09.2017 | 01.10.2018 |
| REVANCE THERAPEUTICS, INC. | Verwaltungsdirektor | 01.10.2013 | 01.09.2017 |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Comptroller/Controller/Auditor | 01.01.2011 | 01.09.2013 |
Ausbildung von Samir Gharib
| Haas School of Business | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
Operativ
| Director of Finance/CFO | 2 |
| Comptroller/Controller/Auditor | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| REVANCE THERAPEUTICS, INC. | Health Technology |
| SPRUCE BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Health Technology |
Stemedica Cell Technologies, Inc.
Stemedica Cell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Stemedica Cell Technologies, Inc. operates as a biotechnology company that manufactures adult allergenic stem cells. Its adult stem cells which are used by research institutions and hospitals for pre-clinical and clinical studies. It has offices in Mexico, Italy, Switzerland, and France. The company was founded by Roger J. Howe and Maynard A. Howe in 2005 and is headquartered in San Diego, CA. | Health Technology |
| Cancer CAREpoint | |
| Benchmark Financial Partners LLC |
- Börse
- Insiders
- Samir Gharib
- Erfahrung
